Terns Pharmaceuticals Inc (TERN) stock news · $6.12B cap
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
This TERN news page leads with what Terns Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for TERN yet. We will not pad this page with generic market recap.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. Revenue was down 100.0% from 2021-12-31 to 2022-12-31. TERN currently screens at market cap $6.12B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the TERN stock page; for the tape open the quote page.
TERN stock news FAQ
What is TERN's latest net income?
Latest cached Terns Pharmaceuticals Inc (TERN) net income was -$60.3M. Statements: https://lician.com/financials/tern
What is TERN's market cap?
Terns Pharmaceuticals Inc (TERN) market cap is $6.12B on the latest cached fundamentals snapshot.
What kind of company is TERN?
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Where is TERN stock news listed?
Cached stock news for Terns Pharmaceuticals Inc (TERN) is listed at https://lician.com/news/tern. Filings: https://lician.com/sec/tern
Not investment advice.